ArticleBMC rheumatology2026

Real-world effectiveness and safety of upadacitinib in Japanese patients with rheumatoid arthritis: impact of age, renal function, and low-dose therapy.

Yuto Tanno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.